HU192231B - Process for production of derivatives of substituated 1-phenil-3-azo-byciclo /3.1.1/-heptan 2,4-dion and medical preparatives containing therof as active substance - Google Patents

Process for production of derivatives of substituated 1-phenil-3-azo-byciclo /3.1.1/-heptan 2,4-dion and medical preparatives containing therof as active substance Download PDF

Info

Publication number
HU192231B
HU192231B HU852418A HU241885A HU192231B HU 192231 B HU192231 B HU 192231B HU 852418 A HU852418 A HU 852418A HU 241885 A HU241885 A HU 241885A HU 192231 B HU192231 B HU 192231B
Authority
HU
Hungary
Prior art keywords
formula
dione
azabicyclo
heptane
compound
Prior art date
Application number
HU852418A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT38346A (en
Inventor
Alex Alder
Jaroslav Stanek
Daniel Bellus
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of HUT38346A publication Critical patent/HUT38346A/hu
Publication of HU192231B publication Critical patent/HU192231B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
HU852418A 1984-06-20 1985-06-19 Process for production of derivatives of substituated 1-phenil-3-azo-byciclo /3.1.1/-heptan 2,4-dion and medical preparatives containing therof as active substance HU192231B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH298784 1984-06-20

Publications (2)

Publication Number Publication Date
HUT38346A HUT38346A (en) 1986-05-28
HU192231B true HU192231B (en) 1987-05-28

Family

ID=4246108

Family Applications (2)

Application Number Title Priority Date Filing Date
HU852418A HU192231B (en) 1984-06-20 1985-06-19 Process for production of derivatives of substituated 1-phenil-3-azo-byciclo /3.1.1/-heptan 2,4-dion and medical preparatives containing therof as active substance
HU864193A HU194180B (en) 1984-06-20 1985-06-19 Process for production of derivatives of 1 /4-nitrophenil/-3-azabyciclo /3,1/ heptane-2,4-dion

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU864193A HU194180B (en) 1984-06-20 1985-06-19 Process for production of derivatives of 1 /4-nitrophenil/-3-azabyciclo /3,1/ heptane-2,4-dion

Country Status (20)

Country Link
US (3) US4677129A (Direct)
EP (1) EP0166692B1 (Direct)
JP (1) JPH0625127B2 (Direct)
KR (1) KR920005494B1 (Direct)
AT (1) ATE54446T1 (Direct)
AU (1) AU584098B2 (Direct)
DD (2) DD245871A5 (Direct)
DE (1) DE3578608D1 (Direct)
DK (1) DK164052C (Direct)
ES (4) ES8801261A1 (Direct)
FI (1) FI83214C (Direct)
GR (1) GR851498B (Direct)
HU (2) HU192231B (Direct)
IE (1) IE58069B1 (Direct)
IL (1) IL75545A0 (Direct)
NO (1) NO166444C (Direct)
NZ (1) NZ212482A (Direct)
PH (1) PH21957A (Direct)
PT (1) PT80659B (Direct)
ZA (1) ZA854613B (Direct)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114033B1 (de) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
EP0166692B1 (de) * 1984-06-20 1990-07-11 Ciba-Geigy Ag Substituierte Azabicycloheptane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
US4883877A (en) * 1987-11-13 1989-11-28 Ciba-Geigy Corporation Azabicycloheptanes and process for their preparation
DE3843481A1 (de) * 1988-12-23 1990-06-28 Boehringer Ingelheim Kg Substituierte 3-azabicyclo/3.1.1/heptane, ihre herstellung und ihre verwendung
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
WO1992021069A1 (fr) 1991-05-14 1992-11-26 Seiko Epson Corporation Dispositif de formation d'image

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE548074A (Direct) *
US2673205A (en) * 1951-02-13 1954-03-23 Ciba Pharm Prod Inc 3-disubstituted dioxopiperidines and the manufacture thereof
US2848455A (en) * 1955-07-18 1958-08-19 Ciba Pharm Prod Inc Alpha-(p-amino-phenyl)-alpha-lower alkyl glutarimides
DE1088957B (de) * 1955-07-18 1960-09-15 Ciba Geigy Verfahren zur Herstellung von ª‡-(p-Amino-phenyl)-ª‡-alkyl-glutarimiden
GB1015618A (en) * 1962-04-10 1966-01-05 Aspro Nicholas Ltd Glutarimide therapeutic compositions
DE1299617B (de) * 1965-01-13 1969-07-24 Degussa Verfahren zur Herstellung von feinverteiltem gefaelltem Siliciumdioxid
US4131611A (en) * 1975-07-31 1978-12-26 American Cyanamid Company Azabicyclohexanes
US4231935A (en) * 1975-07-31 1980-11-04 American Cyanamid Company 1-Phenyl-3-azabicyclo[3.1.0]hexanes
US4435419A (en) * 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
EP0114033B1 (de) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
EP0166692B1 (de) * 1984-06-20 1990-07-11 Ciba-Geigy Ag Substituierte Azabicycloheptane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen

Also Published As

Publication number Publication date
PT80659A (en) 1985-07-01
JPH0625127B2 (ja) 1994-04-06
ES8801261A1 (es) 1987-12-16
ES8802388A1 (es) 1988-05-16
IL75545A0 (en) 1985-10-31
AU4385885A (en) 1986-01-02
FI852429L (fi) 1985-12-21
EP0166692B1 (de) 1990-07-11
US4677129A (en) 1987-06-30
NO166444C (no) 1991-08-07
FI852429A0 (fi) 1985-06-19
ES557122A0 (es) 1988-05-16
ES8801278A1 (es) 1987-12-16
DK277485D0 (da) 1985-06-19
HU194180B (en) 1988-01-28
US4764640A (en) 1988-08-16
EP0166692A3 (en) 1986-11-12
ATE54446T1 (de) 1990-07-15
DE3578608D1 (de) 1990-08-16
IE58069B1 (en) 1993-06-30
NO852478L (no) 1985-12-23
ZA854613B (en) 1986-02-26
DK277485A (da) 1985-12-21
HUT38346A (en) 1986-05-28
US4857660A (en) 1989-08-15
JPS6112666A (ja) 1986-01-21
KR860000265A (ko) 1986-01-27
PH21957A (en) 1988-04-15
GR851498B (Direct) 1985-11-25
EP0166692A2 (de) 1986-01-02
DD245871A5 (de) 1987-05-20
FI83214C (fi) 1991-06-10
PT80659B (en) 1987-05-04
DK164052C (da) 1992-09-28
NO166444B (no) 1991-04-15
FI83214B (fi) 1991-02-28
ES557123A0 (es) 1987-12-16
DK164052B (da) 1992-05-04
KR920005494B1 (ko) 1992-07-06
IE851519L (en) 1985-12-20
AU584098B2 (en) 1989-05-18
ES557121A0 (es) 1988-01-01
NZ212482A (en) 1988-08-30
ES8801214A1 (es) 1988-01-01
DD234419A5 (de) 1986-04-02
ES544319A0 (es) 1987-12-16

Similar Documents

Publication Publication Date Title
US6653320B2 (en) Imidazopyridine derivatives
KR100830859B1 (ko) 이미다조피리딘 유도체 및 이를 함유하는 의약 조성물
JP3140453B2 (ja) インドロカルバゾールおよびその使用
Guan et al. Design of β-carboline derivatives as DNA-targeting antitumor agents
US6268391B1 (en) Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases
CN112778275A (zh) 金刚烷基prmt5抑制剂及其应用
JPWO2001083481A1 (ja) イミダゾピリジン誘導体
JPH11504922A (ja) 蛋白チロシンキナーゼ媒介細胞増殖を抑制するためのピリド［２，３−ｄ］ピリミジン類
HUP0004422A2 (hu) 2-Aril-8-oxohidropurin-származékok, eljárás előállításukra, ilyen vegyületeket tartalmazó gyógyászati készítmények
JP2002514572A (ja) インドール誘導体および悪性疾患および病理的細胞増殖にもとづく他の疾患を治療するためのその使用
JPH11503445A (ja) ｃＧＭＰ−ＰＤＥ阻害剤としてのインドール誘導体
Zelisko et al. Crotonic, cynnamic, and propiolic acids motifs in the synthesis of thiopyrano [2, 3-d][1, 3] thiazoles via hetero-Diels–Alder reaction and related tandem processes
JP2008533172A (ja) チロシン／スレオニンキナーゼ阻害剤、特にＢ−ＲＡＦキナーゼ阻害剤としての、Ｎ−［３−（１−アミノ−５，６，７，８−テトラヒドロ−２，４，４ｂ−トリアザフルオレン−９−イル）−フェニル］ベンズアミド
Xie et al. Epoxide-containing side chains enhance antiproliferative activity of paullones
Farjadmand et al. Synthesis and evaluation of novel quinazolinone-1, 2, 3-triazoles as inhibitors of lipoxygenase
JP2001506997A (ja) ホスホチロシン認識ユニットを有する蛋白質の修飾物質
HU192231B (en) Process for production of derivatives of substituated 1-phenil-3-azo-byciclo /3.1.1/-heptan 2,4-dion and medical preparatives containing therof as active substance
AU2005313485B2 (en) 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
HRP920897A2 (hr) Spojevi indenoindola i postupak za njihovo dobivanje
EP1756112B1 (en) Pyrrolobenzimidazolones and their use as antiproliferative agents
US5356903A (en) 1-cyclopropyl-4-pyridyl-quinolines
WO2004099190A1 (en) Novel substituted benzimidazole derivatives
JP2002512222A (ja) ４−ヒドロキシインドール、インダゾール、及び、カルバゾール化合物の製造方法
JP4014052B2 (ja) インドール誘導体及びその用途
CN118165004A (zh) 一种Type-II型GSK-3β抑制剂及其制备方法与应用

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee